News | January 18, 2024
NATCO invests US$ 2 million in Cellogen Therapeutics
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
A 'better for you' organic brand spanning Food & Beverages and Nutraceutical categories
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
HIFU is a state-of-the-art treatment that utilizes high-frequency sound waves to target and destroy prostate cancer cells
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Subscribe To Our Newsletter & Stay Updated
